A Study of Modified Release Formulations of Danicopan in Healthy Adult Participants
Status:
Completed
Trial end date:
2018-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate and compare the plasma pharmacokinetic profiles of
ACH-0144471 (danicopan) in healthy participants after administration of single oral doses of
modified release prototype formulations.